There is an increasing appreciation that immunological mechanisms play important roles in AD pathogenesis, as evidenced by the identification of a number of genes expressed in immune cells of the central nervous system (CNS) carrying genetic variants associated with increased risk for late-onset AD, including CD33 [75], TREM2 [14, 15], and CR1 [76]. The gene discussed is CD33; the disease is Alzheimer disease.